EPISODE · Jun 5, 2025 · 24 MIN
Streamlining Effective Patient Engagement through Pharma-Patient Advocacy Collaboration
from PharmaTalkRadio · host Conference Forum
About this podcast: Partnerships between industry and patient advocacy groups supply medicine development with critical patient expertise, insights and experience on the journey towards greater patient centricity. This podcast focuses specifically on the role of patient advocacy groups in medicine development in providing a direct, and often untapped, resource for patient insights, community connections and protocol feedback. Dr Matthew Reaney, Scientific Lead, Patient-Centered Solutions at IQVIA, speaks with Trish Davidson, Senior Consultant at the Tufts Center for the Study of Drug Development and Director, PALADIN Consortium about the role of patient advocacy groups in medicine development and how PALADIN is connecting industry stakeholders to reduce duplicative efforts in patient engagement resources and advance more efficient patient engagement across the industry.In the podcast, Matt touches upon IQVIA's recent collection of perspectives from researchers, approvers and patients. The book, Patient-centricity in the Biopharmaceutical Industry: Are We Nearly There Yet? was collated and edited by Matt and gathers diverse insights on patient-centric intervention development. In formats ranging from poetry to short fiction and personal narratives to more traditional reviews of the research, 30+ contributors across the industry discuss how to be truly “patient centric.” It can be accessed for free at https://bit.ly/PatientCentricityBook. For more information on PharmaTalk Radio podcasts, you can visit theconferenceforum.org.
What this episode covers
About this podcast: Partnerships between industry and patient advocacy groups supply medicine development with critical patient expertise, insights and experience on the journey towards greater patient centricity. This podcast focuses specifically on the role of patient advocacy groups in medicine development in providing a direct, and often untapped, resource for patient insights, community connections and protocol feedback. Dr Matthew Reaney, Scientific Lead, Patient-Centered Solutions at IQVIA, speaks with Trish Davidson, Senior Consultant at the Tufts Center for the Study of Drug Development and Director, PALADIN Consortium about the role of patient advocacy groups in medicine development and how PALADIN is connecting industry stakeholders to reduce duplicative efforts in patient engagement resources and advance more efficient patient engagement across the industry.In the podcast, Matt touches upon IQVIA's recent collection of perspectives from researchers, approvers and patients. The book, Patient-centricity in the Biopharmaceutical Industry: Are We Nearly There Yet? was collated and edited by Matt and gathers diverse insights on patient-centric intervention development. In formats ranging from poetry to short fiction and personal narratives to more traditional reviews of the research, 30+ contributors across the industry discuss how to be truly “patient centric.” It can be accessed for free at https://bit.ly/PatientCentricityBook. For more information on PharmaTalk Radio podcasts, you can visit theconferenceforum.org.
NOW PLAYING
Streamlining Effective Patient Engagement through Pharma-Patient Advocacy Collaboration
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.